Tobacco seller Philip Morris International (PM) recently soared to new heights on the back of its blockbuster Q4 2024 ...

While investors in the tobacco space have tended to be more focused on dividends over the years, Philip Morris International ...

Philip Morris delivered strong Q4 results, driven by surging demand for products like IQOS and ZYN. Read why I maintain a ...

Cannabis pouches emerge as an alternative to smoking, but can they match Zyn's success? Experts weigh in on market potential ...

Philip Morris continues to see solid growth led by Zyn. It has a big opportunity in a few years with its IQOS product in the U.S. The stock is attractively valued and still has a nice dividend yield.

We recently published a list of 12 Best FMCG Stocks To Buy According to Hedge Funds. In this article, we are going to take a ...

Philip Morris cited growth in Iqos, its inhalable smoke-free product, as well as Zyn nicotine pouches, which won FDA authorization in 2024.

Tobacco harm reduction advocates in the Philippines lauded the U.S. Food and Drug Administration’s marketing authorizations ...

Philip Morris International (NYSE:PM – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” ...

Local proponents of tobacco harm reduction have welcomed the recent U.S. Food and Drug Administration’s (FDA) marketing ...